New Drug Cures Some Blood Cancer Patients in Trials

Friday, 08 Nov 2013 12:59 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Geron Corp said 22 percent of trial patients treated with its experimental blood cancer drug were now free of the disease, a major break for the company after two big setbacks.
Shares of Geron more than doubled in morning trade on Thursday to a four-year high.
"This is going to save the company, because it's the last thing that they had," MLV & Co analyst George Zavoico told Reuters. "This truly opens the door for other opportunities in other indications."
Geron earlier failed to develop the blood cancer drug, imetelstat, to treat breast cancer. It also stopped working on its brain cancer drug.
Imetelstat is designed to treat myelofibrosis, a rare form of blood cancer.
Zavoico said the data validated imetelstat's "mechanism of action" and suggested it was superior to Incyte Corp's Jakafi, which is approved to treat myelofibrosis.
Imetelstat is designed to inhibit telomerase, an enzyme that enables rapid multiplication of cancer cells.
Jakafi inhibits another family of enzymes, reducing cell multiplication. The drug had sales of $136 million in 2012.
Zavoico said Jakafi reduced spleen size and relieved symptoms, but did not have a disease-modifying effect, defined as partial or complete remission.
Geron said one patient of the first 18 enrolled in the trial showed partial remission.
The company released the data ahead of a presentation on December 9 at the annual meeting of the American Society of Hematology.
 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Is Tau the 'How' Behind Alzheimer's?

Friday, 31 Oct 2014 16:29 PM

Malfunction of a key brain protein called tau is the likely culprit behind Alzheimer's disease and other forms of dement . . .

Sleep Apnea Tied to Memory Loss

Friday, 31 Oct 2014 16:20 PM

The ability to remember locations and directions may suffer when deep sleep is disrupted by breathing difficulties, a ne . . .

'Ebola Mice' Developed to Fast-Track Vaccine Research

Friday, 31 Oct 2014 15:18 PM

Researchers have developed the first genetic strain of mice that can be infected with Ebola and used to test new drugs a . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved